Sharon Mates
CIK 1585699 · Chairman and CEO · last filed 2026-05-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
76
Lifetime Open-Market Net
-$83.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 8
76 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-23 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | — | -$6.96M | EDGAR |
| 2024-08-22 | — | Notice (144) | −39,380 | -$2.94M | EDGAR |
| 2024-08-21 | — | Notice (144) | −53,013 | -$4.01M | EDGAR |
| 2024-04-25 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Exer (M) | +20,020 | $345.6K | EDGAR |
| 2024-03-11 | — | Notice (144) | −20,565 | -$1.34M | EDGAR |
| 2024-03-11 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | −40,712 | -$4.05M | EDGAR |
| 2024-03-08 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Exer (M) | +40,712 | $0 | EDGAR |
| 2024-03-07 | — | Notice (144) | −40,712 | -$2.71M | EDGAR |
| 2024-03-05 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-27 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | — | -$1.58M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.